版本:
中国

BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease

April 3 Teva Pharmaceutical Industries Ltd -

* Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with huntington’s disease

* AUSTEDO is expected to be available in U.S. within next 3 weeks. Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐